NCT00416767View on ClinicalTrials.gov

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

July 31, 2007

Conditions
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Interventions
DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

All Listed Sponsors
lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT00416767 - Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter